10x Genomics (TXG)

Last Closing Price: 57.07 (2026-11-18)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

10x Genomics (TXG) had Net Income of $-19.43M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$150.67M
Net Income
$-19.43M
$37.74M
$112.93M
$166.72M
$-16.06M
$-2.42M
$-18.48M
$-18.48M
$-19.43M
$-19.43M
$-19.43M
$-19.43M
$-16.06M
$-4.45M
130.81M
130.81M
$-0.15
$-0.15
Balance Sheet Financials
$718.63M
$210.24M
$344.50M
$1.06B
$140.37M
--
$84.72M
$225.09M
$838.04M
$772.46M
$838.04M
131.53M
Cash Flow Statement Financials
$58.93M
$-9.55M
$3.12M
$473.97M
$526.19M
$52.22M
$71.35M
--
--
Fundamental Metrics & Ratios
5.12
--
--
--
--
74.95%
-10.66%
-10.66%
--
-12.26%
-12.89%
$54.77M
--
--
--
0.14
0.58
2.56
35.10
-2.32%
-2.51%
-1.83%
-2.32%
$6.37
$0.42
$0.45